… release (IR) and extended release (ER) formulations, and ER MPH has become increasingly
dominant in recent years [19, 20]. Osmotic release oral system … and equivalent effectiveness …

… An open-label, four-arm, Phase 2a trial to test the efficacy of … accumulated by halophile
bacteria to withstand osmotic stress [Citation58]. … The results of a prospective, active-controlled, …

… al. formulated an osmotic release strategy of cyclosporine via … In a randomized, active-controlled
phase 2/3 study, tregopil … First of all, a prospective, single-center, open-label, phase 1 …

… of receiving osmotic-release oral system methylphenidate (… head randomized clinical trial
was a 24-week open-label study… Similar findings were noted in the RVIP. The probability of …

… Arbaclofen extended-release (ER) employs osmotic pump technology to … , randomized
placebo- and active-controlled trial demonstrated that 40 mg/day arbaclofen ER had similar …

… randomly assigned to osmotic-release oral system methylphenidate (n = 83) and atomoxetine
(n = 85) in a 24-week, open-label, head-to-head clinical trial. … have comparable efficacy in …

… of one randomized, placebo- and active-controlled trial of lisdexamfetamine (osmotic-release …
A multi-centre, randomised, open-label study of atomoxetine compared with standard …

… , randomized, rater-blinded, active-controlled trial conducted … Similar to the present study,
in a large, population-based cohort … Two open-label trials have demonstrated improved …

… was developed using an oral osmotic pump technology. Later… were generated in an open-label,
randomized, phase I study … a double-blind, randomized, active-controlled, parallel-group …

… with dry eye disease underwent an open-label, 7-day run-in … cells to help balance the osmotic
stress without causing cell … AE was reported by a similar percentage of subjects in the OM3 …